Articles from OSSTEC

OSSTEC, an orthopedic company developing 3D-printed cementless joint replacement implants, today announced it has closed $8 million to fund the first-in-human U.S. surgical cases of ASCENT, its cementless, fixed-bearing partial knee system. The round was led by EMBRYO Ventures, with participation from Neovate Capital, New Wave Ventures, Oxford Technology Innovation Finance and Empirical Ventures.

OSSTEC, a UK-based orthopaedics company developing next-generation cementless knee replacement technology, today announced updates supporting its US market entry: The appointment of Dr. Nick Pachuda to its Board of Directors and the establishment of US operations led by US Commercial Lead Christopher Campbell.